Clearstead Trust’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.6K Hold
1,487
﹤0.01% 432
2026
Q1
$20.1K Hold
1,487
﹤0.01% 436
2025
Q4
$18.5K Buy
1,487
+287
+24% +$3.1K ﹤0.01% 451
2025
Q3
$11.9K Buy
1,200
+169
+16% +$1.65K ﹤0.01% 556
2025
Q2
$9.21K Buy
1,031
+251
+32% +$2.12K ﹤0.01% 610
2025
Q1
$6.79K Hold
780
﹤0.01% 534
2024
Q4
$9.71K Buy
780
+736
+1,673% +$9.05K ﹤0.01% 357
2024
Q3
$511 Hold
44
﹤0.01% 410
2024
Q2
$468 Sell
44
-41
-48% -$453 ﹤0.01% 429
2024
Q1
$1.01K Buy
85
+41
+93% +$494 ﹤0.01% 418
2023
Q4
$477 Sell
44
-170
-79% -$1.63K ﹤0.01% 407
2023
Q3
$2.11K Hold
214
﹤0.01% 414
2023
Q2
$2.14K Sell
214
-82
-28% -$783 ﹤0.01% 360
2023
Q1
$2.85K Sell
296
-233
-44% -$2.58K ﹤0.01% 336
2022
Q4
$6K Sell
529
-293
-36% -$3.06K ﹤0.01% 333
2022
Q3
$7K Buy
+822
New +$8.09K ﹤0.01% 310

Other funds holding VTRS

Clearstead Trust's VTRS Position: Q2 2026 in Review

Clearstead Trust held its Viatris (VTRS) position steady in Q2 2026 at 1,487 shares worth $23.6K. The position accounts for ﹤0.01% of the portfolio, ranked #432.

Clearstead Trust first reported a position in VTRS in Q3 2022 and has held it in 16 quarters since. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Clearstead Trust held 1,487 shares of Viatris worth $23.6K as of Q2 2026.
  • Clearstead Trust left its Viatris share count unchanged in Q2 2026.
  • Viatris made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #432 holding.
  • Clearstead Trust first reported a position in Viatris in Q3 2022 and has held it in 16 quarters since.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.